| Financial Year |
March 31 2023 |
| Monetary Funds |
3,496,591,242.51 |
| Held-for-trading Financial Assets |
1,022,124,622.19 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,150,440,057.74 |
| Advances to Suppliers |
88,812,774.61 |
| Other Receivables |
18,367,690.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,406,231,328.24 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
118,578,268.81 |
| Total Current Assets |
8,337,084,673.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
9,011,724,505.93 |
| Under-construction Projects |
1,685,322,727.07 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
150,221,341.82 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
8,529,618.11 |
| Deferred Income Tax Assets |
48,067,740.63 |
| Other Non-Current Assets |
103,187,477.00 |
| Sub-Total of Non-Current Assets |
11,269,210,609.21 |
| Total Assets |
19,606,295,282.60 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
7,701,594.34 |
| Notes Payable |
3,520,574,717.03 |
| Accounts Payable |
1,893,743,731.37 |
| Accounts Received In Advance |
2,403,648.75 |
| Employee Compensation Payable |
59,675,797.68 |
| Taxes Payable |
64,574,948.60 |
| Interest Payable |
-- |
| Dividend Payable |
1,594,463.14 |
| Other payables |
110,631,671.84 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
700,396,670.51 |
| Other Current Liabilities |
54,360,639.75 |
| Sub-Total of Current Liabilities |
6,516,806,128.13 |
| Long-term Loans |
5,568,312,038.90 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,615,302,401.77 |
| Total Liabilities |
12,132,108,529.90 |
| Paid-In Capital(Or Share Stock) |
396,688,445.00 |
| Capital Surplus |
4,871,953,982.84 |
| Surplus Reserve |
203,927,628.24 |
| LESS:Treasury Stock |
9,887,411.78 |
| Undistributed Profits |
2,010,683,690.93 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,474,186,752.70 |
| Owner's Equity（Stockholder's Equity） |
7,474,186,752.70 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
19,606,295,282.60 |
